Navigation Links
FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility
Date:6/29/2011

SEATTLE, June 29, 2011 /PRNewswire/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that the U.S. Food and Drug Administration (FDA) approved its Los Angeles cancer immunotherapy manufacturing facility, allowing the company to continue to increase the availability of PROVENGE® (sipuleucel-T) across the U.S. to help meet the needs of patients with asymptomatic or minimally symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.  

The Los Angeles facility includes 36 workstations, and Dendreon will bring these new workstations online in a staged approach. With this FDA approval and the fully approved New Jersey facility, Dendreon now has total of 84 workstations available to manufacture PROVENGE. Dendreon expects to continue to provide additional capacity through the anticipated licensure mid-year of one other manufacturing facility in the United States.  In April, Dendreon filed a post-approval supplement for its third facility in Atlanta, for which there is an FDA action date of August 28, 2011.

PROVENGE is designed to induce an immune response against prostatic acid phosphatase (PAP), an antigen expressed in most prostate cancers, and is the first in a new therapeutic class of drugs known as autologous cellular immunotherapies.

"As the foundation of care, PROVENGE is an important treatment option for men with metastatic castrate resistant prostate cancer," said Mitchell H. Gold, M.D., president and chief executive officer of Dendreon. "The FDA approval of the Los Angeles facility will enhance our ability to provide PROVENGE to the many patients across the country who may benefit from it."  

In anticipation of the availability of the additional workstations, Dendreon expects to have approximately 225 active infusing sites by the end of the second quarter and approximately 500 by the end
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. FDA Approves New Device to Treat Brain Aneurysms
2. European Commission Approves DuPont Tender Offer to Acquire Danisco
3. New York State Approves the Quest Diagnostics ColoVantage™ Colorectal Cancer Blood Test
4. European Medicines Agency Approves Pediatric Investigational Plan for Pixuvri
5. FDA Approves KRYSTEXXA™ (pegloticase) for the Treatment of Chronic Gout in Adult Patients Refractory to Conventional Therapy
6. European Union Approves Maize with Herculex® I/Herculex® RW and Herculex® RW/ Herculex® I/Roundup Ready® Corn 2 Trait Stacks for Import, Food, Feed & Processing
7. FDA Approves First-of-Its-Kind HIV Test Which Can Detect HIV Days Earlier Than Current U.S. Tests
8. Aeterna Zentaris: FDA Approves Investigational New Drug (IND) Application for Doxorubicin Targeted Conjugate Compound, AEZS-108, in Bladder Cancer
9. FDA Approves Five-Day Dosing Regimen for Dacogen(R) (decitabine) for Injection, Offering a New Outpatient Dosing Option for Myelodysplastic Syndromes (MDS)
10. European Union Approves Corn Stack with Herculex RW and Roundup Ready 2 Traits for Food, Feed, Import and Processing
11. EU Committee Approves New Food Applications for Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/16/2013)... This training is ideal for those who will ... software industry or those who want to explore Agile and ... The topics that will be covered in the 1-day Agile ... scrum artifacts, and scrum simulation (optional). , The trainings ... June 28, 2013 , Click here to register for a ...
(Date:6/14/2013)... June 14, 2013 These couplings are ... come equipped with a new and improved “Easy Grip ... more secure grip and reliable connection every time. , ... for use on medical applications such as ... pressure cuff manufacturers with better, more reliable, high quality, ...
(Date:6/14/2013)... Rosacea is said to affect 16 million Americans, eczema, ... it seems that most of the population have one or ... reports, often deciphering the difference between one skin condition ... have similar symptoms. Probiotic Action explains how these skin conditions ... effectively. , Rosacea, Acne and Eczema are conditions that react ...
(Date:6/14/2013)... , June 14, 2013  The Pittsburgh Life Sciences ... levels of investment that were necessitated by delays in ... investment climate and the uncertainty of state funding. ... said, "As the region,s only pure life sciences investment ... by the PLSG Board of Directors, were necessary to ...
Breaking Biology Technology:Affordable Scrum Trainings in Denver, CO – 8 PDUs (June 28, 2013) by Conscires Agile Practices 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 2LinkTech Inc. Launches Ideal Replacement for a Luer Fitting 3Rosacea, Acne, or Eczema? Probiotic Action Offers a Topical Probiotic to Treat the Most Common Skin Conditions 2Pittsburgh Life Sciences Greenhouse Makes Significant Reductions Due to Uncertain Funding 2
... ... investment bank KTA Capital,s client Neuren Pharmaceuticals Ltd (ASX:NEU) has agreed an AU$6.7 mil ... by KTA Capital as Neuren,s exclusive placement agent and advisor. , ... New York (PRWEB) November 23, 2009 ...
... ... field remains the only one to show consistent growth during the U.S. recession. However, clinics ... actually cut medical personnel, instead of just administrators. , ... (Vocus) November 24, 2009 -- Health care employment continued growing in ...
... 24 Blue Marble Energy Corp. announced today that ... were recently awarded $2 million by Washington State,s Community ... construct the state,s first specialty biochemical biorefinery in Lincoln ... speed the development of our biorefinery and bring over ...
Cached Biology Technology:KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
(Date:6/16/2013)... HIV prevention programs for female sex workers in India ... infections (STIs), a University of Toronto study has found. ... with HIV, mostly in the southern states of Andhra ... by Professor Prabhat Jha from U of T,s Dalla ... Centre for Global Health Research (CGHR), examined the impact ...
(Date:6/16/2013)... snap" 116 million years ago triggered a similar marine ... a result of global warming, according to research published ... involving experts from the universities of Newcastle, UK, Cologne, ... and a crash in the marine ecosystem during the ... the first time the amplitude and duration of the ...
(Date:6/14/2013)... Oklahoma researchers will collaborate with researchers from Oklahoma ... the University of Tulsa to advance understanding of ... climate change and variability in the state. , ... receive a $20 million National Science Foundation Experimental ... strategically aligned, innovative research over the next five ...
Breaking Biology News(10 mins):HIV prevention among female sex workers in India reduces HIV and syphilis 2Global cooling as significant as global warming 2OU researchers collaborate on $20 million NSF EPSCoR grant 2OU researchers collaborate on $20 million NSF EPSCoR grant 3
... An international team of scientists, including botanists from the University ... be used to catalogue the world,s plants using a technique ... method that uses a short genetic marker in an organism,s ... "Barcoding provides an efficient means by which we can ...
... promising data from a clinical study showing patient-specific ... and immune cells were well tolerated and resulted ... metastatic melanoma whose disease had been minimized by ... "Phase II Trial of Dendritic Cells Loaded with ...
... Mitochondrial diseases disrupt the power generating machinery within cells ... in the lungs or respiratory tract. A new study ... shows that infection with the pneumonia causing bacteria ... a signaling protein that is associated with mitochondrial disease. ...
Cached Biology News:University of Toronto helps to 'barcode' the world's plants 2Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma 2Stress signals link pre-existing sickness with susceptibility to bacterial infection 2
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles...
...
TRIzol Reagents are ready-to-use monophasic solutions of phenol and guanidine isothiocyanate suitable for isolating total RNA DNA and proteins (16)....
...
Biology Products: